Your trusted partner
We’re committed to helping consultants succeed
We deliver a pharmacy care experience that offers affordability, experience, and simplicity. You bring your clients solutions that attract and retain employees. Together, we can build a strong, healthy workforce that sets a global standard for excellence.
We’re here for you
Whether you need support for your prescription benefit management (PBM) request for proposal (RFP), are faced with a client’s administrative question or require a benefit solution, our Consultant Relations Team provides white glove, concierge service all designed to help you do what you do best - help your clients.
Investing & innovating
We developed CarelonRx because we wanted our clients to have the PBM experience worthy of the nation’s leading health plan. We have invested, and continue to invest, in capabilities, partnerships and companies that will allow us to deliver on our mission. We’re controlling the levers that matter for a connected, whole-health experience.
Investments and innovations to drive the future of pharmacy
Synergie Medication Collective
nationwide contracting organization founded by BCBS to improve affordability of costly medical specialty drugs
BioPlus Specialty Pharmacy
ranked #1 in provider satisfaction, industry-leading time to therapy
CarelonRx Pharmacy
digital first, concierge pharmacy with enhanced adherence driving savings
Paragon Healthcare
specialty infusion therapy drives affordability through site of care savings.
CivicaScript
new medication collective to bring more savings to common higher priced generic drugs
310M
pharmacy claims annually
34B
pharmacy revenue
10M+
prescriptions managed
6M+
members
Entrepreneurial mindset, solid foundation
Launched by one of the nation’s largest health organizations— Anthem Blue Cross Blue Shield — at CarelonRx, we draw from a deep reservoir of pharmacy and medical insights. This expertise helps us drive better health outcomes, lower costs, and simplify pharmacy experiences.
*All stats CarelonRx Internal data, FY 2023
